Vicore Pharma AB
Nasdaq VCRE · Stockholm, Sweden
Works in Cardiovascular · Dermatology · Infectious disease · Psychiatry · Respiratory
Vicore Pharma AB is a clinical trial sponsor based in Stockholm, Sweden, listed as Nasdaq VCRE. It has 1 active clinical trial with 378 planned participants, across 5 therapeutic areas. Since 2021 it has completed 10 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq VCRE
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Vicore Pharma AB
Vicore Pharma AB is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 378 planned participants, in Cardiovascular, Dermatology, Infectious disease, Psychiatry and other areas. Since 2021 it has completed 10 trials and stopped 0 early.
Vicore Pharma AB is based in Stockholm, Sweden and is listed as Nasdaq VCRE. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Vicore Pharma AB; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-08-17.
Approve Suite is not affiliated with Vicore Pharma AB.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.